Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo. - Mao J; Chen Y; Zong Q; Liu C; Xie J; Wang Y; Fisher D; Hien NTT; Pronyuk K; Musabaev E; Li Y; Zhao L; et al. (Frontiers in immunology, 2024)